Clinical Schizophrenia & Related Psychoses

Google Scholar citation report

Citations : 6601

Clinical Schizophrenia & Related Psychoses received 6601 citations as per Google Scholar report

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

	2022	2021	2020	2019	2018
Year wise published articles	105	141	28	8	28
Year wise citations received	543	553	590	563	587

Journal total citations count	6601
Journal Impact Factor	6.49
Journal 5 years Impact Factor	12.17
Journal CiteScore	11.19
Journal h-index	41
Journal h-index since 2016	26

Zheng, Crystal Y., Caterina P. Minniti, and Mark H. Chaitowitz. "Sickle cell crisis complicated by synthetic cannabinoid abuse: a case report." Hemoglobin 40, no. 3 (2016): 220-222. View at Publisher View at Google Scholar View at Indexing
Steffens, M., B. Becker, C. Neumann, A. M. Kasparbauer, I. Meyhöfer, B. Weber, M. A. Mehta, R. Hurlemann, and U. Ettinger. "Effects of ketamine on brain function during smooth pursuit eye movements." Human brain mapping 37, no. 11 (2016): 4047-4060. View at Publisher View at Google Scholar View at Indexing
Demro, Caroline, Laura Rowland, S. Andrea Wijtenburg, James Waltz, James Gold, Emily Kline, Elizabeth Thompson, Gloria Reeves, L. Elliot Hong, and Jason Schiffman. "Glutamatergic metabolites among adolescents at risk for psychosis." Psychiatry research 257 (2017): 179-185. View at Publisher View at Google Scholar View at Indexing
Kantrowitz, Joshua T. "N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia." Schizophrenia research 207 (2019): 70-79. View at Publisher View at Google Scholar View at Indexing
Chehovich, Charisse, and Tammie Lee Demler. "Implications of Clozapine Complications in Geriatric Patients with Type II Diabetes Mellitus." OBM Geriatrics 4, no. 1 (2020): 1-1. View at Publisher View at Google Scholar View at Indexing
Lange, Jos HM, Jennifer Venhorst, Maria JP van Dongen, Jurjen Frankena, Firas Bassissi, Natasja MWJ de Bruin, Cathaline den Besten et al. "Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors." European journal of medicinal chemistry 46, no. 10 (2011): 4808-4819. View at Publisher View at Google Scholar View at Indexing
Barzilay, R., T. Ben-Zur, O. Sadan, Z. Bren, M. Taler, N. Lev, I. Tarasenko et al. "Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice." Translational Psychiatry 1, no. 12 (2011): e61-e61. View at Publisher View at Google Scholar View at Indexing
Leppik, Liisa, Kärt Kriisa, Kati Koido, Kadri Koch, Kärolin Kajalaid, Liina Haring, Eero Vasar, and Mihkel Zilmer. "Profiling of amino acids and their derivatives biogenic amines before and after antipsychotic treatment in first-episode psychosis." Frontiers in psychiatry 9 (2018): 155. View at Publisher View at Google Scholar View at Indexing
Chue, Pierre, and Bogdan Neagu. "Antipsychotic Drugs." In Side Effects of Drugs Annual, vol. 36, pp. 59-84. Elsevier, 2014. View at Publisher View at Google Scholar View at Indexing
Pan, Bo, Xu-Feng Huang, and Chao Deng. "Chronic administration of aripiprazole activates GSK3?-dependent signalling pathways and up-regulates GABA A receptor expression and CREB1 activity in rats." Scientific reports 6, no. 1 (2016): 1-12. View at Publisher View at Google Scholar View at Indexing
Goetz, Ryan L., and Brian J. Miller. "Total and differential white blood cell counts, cocaine, and marijuana use in patients with schizophrenia." The Journal of nervous and mental disease 207, no. 8 (2019): 633-636. View at Publisher View at Google Scholar View at Indexing
Knyahnytska, Yuliya. "Changing the conversation: A critical ethnography of diabetes care in people with mental illnesses." PhD diss., University of Toronto (Canada), 2017. View at Publisher View at Google Scholar View at Indexing
Fleischman, Anat, and Ido Lurie. "Cardiovascular mortality and related risk factors among persons with schizophrenia: A review of the published literature." Public Health Reviews 34, no. 2 (2012): 11. View at Publisher View at Google Scholar View at Indexing
Garay, Ricardo P., Ludovic Samalin, Ahcene Hameg, and Pierre-Michel Llorca. "Investigational drugs for anxiety in patients with schizophrenia." Expert opinion on investigational drugs 24, no. 4 (2015): 507-517. View at Publisher View at Google Scholar View at Indexing
Legge, Sophie E., Marcos L. Santoro, Sathish Periyasamy, Adeniran Okewole, Arsalan Arsalan, and Kaarina Kowalec. "Genetic architecture of schizophrenia: a review of major advancements." Psychological medicine (2021): 1-10. View at Publisher View at Google Scholar View at Indexing
Lafeuille, Marie-Hélène, Neeta Tandon, Sean Tiggelaar, Rhiannon Kamstra, Patrick Lefebvre, Edward Kim, Yong Yue, and Kruti Joshi. "Economic impact in Medicaid beneficiaries with schizophrenia and cardiometabolic comorbidities treated with once-monthly paliperidone palmitate vs. oral atypical antipsychotics." Drugs-real world outcomes 5, no. 1 (2018): 81-90. View at Publisher View at Google Scholar View at Indexing
Summers, Philip J., Robert M. Layne, Amanda C. Ortega, Gareth P. Harris, Bruce A. Bamber, and Richard W. Komuniecki. "Multiple sensory inputs are extensively integrated to modulate nociception in C. elegans." Journal of Neuroscience 35, no. 28 (2015): 10331-10342. View at Publisher View at Google Scholar View at Indexing
Gargiulo, Pascual Ángel, and Adriana Inés Landa De Gargiulo. "Glutamate and modeling of schizophrenia symptoms: review of our findings: 1990–2014." Pharmacological Reports 66, no. 3 (2014): 343-352. View at Publisher View at Google Scholar View at Indexing
Nanasawa, Hideki, Akahito Sako, Tomohiko Mitsutsuka, Kaori Nonogaki, Tadayuki Kondo, Shuichi Mishima, Yoriyasu Uju et al. "Development of diabetes mellitus associated with quetiapine: A case series." Medicine 96, no. 3 (2017). View at Publisher View at Google Scholar View at Indexing
Jerrell, Jeanette M., Roger S. McIntyre, and George B. Black. "Economic grand rounds: economic costs of failure to monitor adverse effects of second-generation antipsychotics: an underestimated factor." Psychiatric Services 63, no. 3 (2012): 202-204. View at Publisher View at Google Scholar View at Indexing
Prev 1 2 ... 29 30 31 32 33 34 35 36 37 38 39 ... 84 85 Next »

Google Scholar citation report

Citations : 6601

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In

PMC/PubMed Indexed Articles

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Zheng, Crystal Y., Caterina P. Minniti, and Mark H. Chaitowitz. "Sickle cell crisis complicated by synthetic cannabinoid abuse: a case report." Hemoglobin 40, no. 3 (2016): 220-222.

Steffens, M., B. Becker, C. Neumann, A. M. Kasparbauer, I. Meyhöfer, B. Weber, M. A. Mehta, R. Hurlemann, and U. Ettinger. "Effects of ketamine on brain function during smooth pursuit eye movements." Human brain mapping 37, no. 11 (2016): 4047-4060.

Demro, Caroline, Laura Rowland, S. Andrea Wijtenburg, James Waltz, James Gold, Emily Kline, Elizabeth Thompson, Gloria Reeves, L. Elliot Hong, and Jason Schiffman. "Glutamatergic metabolites among adolescents at risk for psychosis." Psychiatry research 257 (2017): 179-185.

Kantrowitz, Joshua T. "N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia." Schizophrenia research 207 (2019): 70-79.

Chehovich, Charisse, and Tammie Lee Demler. "Implications of Clozapine Complications in Geriatric Patients with Type II Diabetes Mellitus." OBM Geriatrics 4, no. 1 (2020): 1-1.

Leppik, Liisa, Kärt Kriisa, Kati Koido, Kadri Koch, Kärolin Kajalaid, Liina Haring, Eero Vasar, and Mihkel Zilmer. "Profiling of amino acids and their derivatives biogenic amines before and after antipsychotic treatment in first-episode psychosis." Frontiers in psychiatry 9 (2018): 155.

Chue, Pierre, and Bogdan Neagu. "Antipsychotic Drugs." In Side Effects of Drugs Annual, vol. 36, pp. 59-84. Elsevier, 2014.

Pan, Bo, Xu-Feng Huang, and Chao Deng. "Chronic administration of aripiprazole activates GSK3?-dependent signalling pathways and up-regulates GABA A receptor expression and CREB1 activity in rats." Scientific reports 6, no. 1 (2016): 1-12.

Goetz, Ryan L., and Brian J. Miller. "Total and differential white blood cell counts, cocaine, and marijuana use in patients with schizophrenia." The Journal of nervous and mental disease 207, no. 8 (2019): 633-636.

Knyahnytska, Yuliya. "Changing the conversation: A critical ethnography of diabetes care in people with mental illnesses." PhD diss., University of Toronto (Canada), 2017.

Fleischman, Anat, and Ido Lurie. "Cardiovascular mortality and related risk factors among persons with schizophrenia: A review of the published literature." Public Health Reviews 34, no. 2 (2012): 11.

Garay, Ricardo P., Ludovic Samalin, Ahcene Hameg, and Pierre-Michel Llorca. "Investigational drugs for anxiety in patients with schizophrenia." Expert opinion on investigational drugs 24, no. 4 (2015): 507-517.

Legge, Sophie E., Marcos L. Santoro, Sathish Periyasamy, Adeniran Okewole, Arsalan Arsalan, and Kaarina Kowalec. "Genetic architecture of schizophrenia: a review of major advancements." Psychological medicine (2021): 1-10.

Summers, Philip J., Robert M. Layne, Amanda C. Ortega, Gareth P. Harris, Bruce A. Bamber, and Richard W. Komuniecki. "Multiple sensory inputs are extensively integrated to modulate nociception in C. elegans." Journal of Neuroscience 35, no. 28 (2015): 10331-10342.

Gargiulo, Pascual Ángel, and Adriana Inés Landa De Gargiulo. "Glutamate and modeling of schizophrenia symptoms: review of our findings: 1990–2014." Pharmacological Reports 66, no. 3 (2014): 343-352.

Nanasawa, Hideki, Akahito Sako, Tomohiko Mitsutsuka, Kaori Nonogaki, Tadayuki Kondo, Shuichi Mishima, Yoriyasu Uju et al. "Development of diabetes mellitus associated with quetiapine: A case series." Medicine 96, no. 3 (2017).

Jerrell, Jeanette M., Roger S. McIntyre, and George B. Black. "Economic grand rounds: economic costs of failure to monitor adverse effects of second-generation antipsychotics: an underestimated factor." Psychiatric Services 63, no. 3 (2012): 202-204.